Vanderbilt Researchers to Use Waters' Synapt in Oncology Studies | GenomeWeb
NEW YORK (GenomeWeb News) – Waters announced today that researchers at Vanderbilt University will use the firm’s Synapt HDMS system to enhance their tissue imaging capabilities in oncology studies being conducted at the school’s Mass Spectrometry Research Center.
 
Researchers at the center are using mass spec technologies to identify and visualize protein expression changes in cells through various stages of cancer.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.